Equities Research Analysts’ Price Target Changes for October 31st (ABBV, ADP, ALKT, ALL, ALRS, ALTR, AMGN, ARCC, ARGX, AVDL)
Equities Research Analysts’ price target changes for Thursday, October 31st: AbbVie (NYSE:ABBV) had its target price boosted by UBS Group AG from $195.00 to $200.00. The firm currently has a neutral rating on the stock. Automatic Data Processing (NASDAQ:ADP) had its target price increased by Royal Bank of Canada from $267.00 to $315.00. They currently […]
31 Oct 16:11 · The Cerbat Gem